Hawryluk P. Kent (CIK 1673991) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-08). Recent activity: Sell MBX (607 shares), Buy MBX (18,500 shares), Buy MBX (28,768 shares), Buy MBX (35,250 shares), Buy MBX (182,859 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | MBX Biosciences, Inc. (MBX) | President & CEO | Sell | 607 | $17,931 |
| 2026-03-16 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 18,500 | $525,585 |
| 2026-02-27 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 28,768 | $460,288 |
| 2026-02-03 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 35,250 | $0 |
| 2025-10-28 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 182,859 | $594,292 |
| 2025-10-21 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 20,000 | $272,800 |
| 2025-02-05 | MBX Biosciences, Inc. (MBX) | President & CEO | Buy | 50,000 | $534,500 |
Source: SEC Form 4 filings · as of 2026-05-08